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Abstract
Background: Identifying the endogenous RNA induced silencing complex(RISC)-associated RNAs
is essential for understanding the cellular regulatory networks by miRNAs. Recently, isolation of
RISC-associated mRNAs using antibody was reported, but their method needs a large amount of
initial materials. We tried to improve the protocol and constructed an efficient and convenient
system for analyzing miRNA and mRNA contents in RISC.
Findings:  With our protocol, it is possible to clone both miRNAs and mRNAs from the
endogenous RISC-associated RNAs immunoprecipitated from less than 107 cells, and we show the
ability of our system to isolate the particular target mRNAs for a specific miRNA from the RISC-
associated mRNAs using well-characterized miR-122 as an example. After introduction of miR-122
into HepG2 cells, we found several cDNA clones that have miR-122 target sequences. Four of
these clones that were concentrated in RISC but decreased in total RNA fraction are expected to
be miR-122 target candidates. Interestingly, we found substantial amounts of Alu-related
sequences, including both free Alu RNA and Alu-embedded mRNA, which might be one of the
general targets for miRNA, in the cDNA clones from the RISC-associated mRNAs.
Conclusion: Our method thus enables us to examine not only dynamic changes in miRNA and
mRNA contents in RISC but also the relationship of miRNA and target mRNA. We believe that
our method can contribute to understanding cellular regulatory networks by miRNAs.
Background
MicroRNAs (miRNAs) are approximately 22-nucleotide
endogenous non-coding RNAs that play important roles
in post-transcriptional regulation of gene expression by
base-pairing to their target mRNAs [1]. After being tran-
scribed and processed, mature miRNAs are incorporated
into the Argonaute protein family, the core component of
the RNA-induced silencing complex (RISC), for targeting
mRNAs based on sequence complementation in 3'UTRs
[2-4]. In humans, the Argonaute family consists of eight
members, divided into the Ago subfamily (Ago1-Ago4)
and Piwi subfamily (PIWIL1-PIWIL4) [5]. Although all
four Ago subfamily members have been implicated in
translational inhibition of mRNA [6], only one Ago pro-
tein, Ago2, possesses intrinsic endonuclease activity.
Experiments in mice and human cell lines have shown
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that Ago2 is the central RISC component, capable of cleav-
ing target mRNA when perfect complementarity with it
exists [7-12].
Identifying the target mRNA against miRNA is essential to
understand cellular regulatory networks by miRNAs. Due
to the low complementarity between a miRNA and its tar-
get mRNAs, only a few mammalian target mRNAs have
been identified. Combinations of biochemical and com-
putational approaches have been started to elucidate how
mRNA targets are specifically recognized by miRNAs.
Among biochemical approaches, recovery of miRNA from
RISC using antibody [13-16] has already been reported,
and recently that of RISC-associated mRNA from the
immunoprecipitates was also reported [17-21]. However,
isolation of RISC-associated mRNA has mainly been per-
formed using exogenously introduced Tagged-Ago2 or
GW182 in combination with antibodies to the Tag [18-
21], and the protocol needs improvement for the efficient
analysis of the RISC-associated mRNA without using large
amounts of initial materials [17].
Methods
Cell culture and transfection
HeLa, HEK293, and HepG2 cells were grown in DMEM
supplemented with 10% fetal calf serum. THP-1 and
P388D1 cells were grown in RPMI1640 supplemented
with 10% fetal calf serum. Transfection of HepG2 cells
was performed using Lipofectamine RNAi max reagent
(Invitrogen). A total of 5 × 106 cultured cells were trans-
fected with 600 pmol miR-122 siRNA (5'-UGGAGUGU-
GACAAUGGUGUUUGU-3', 5'-
AAACACCAUUGUCACACUCCAUA-3') or control siRNA
firefly luciferase GL3 (Nippon Gene) according to the
manufacturer's instructions. After 24 hours, transfected
cells were collected.
Immunoprecipitation and RNA purification
Cultured cells (5 × 106~1 × 107 cells) were collected by
trypsinization and washed with PBS(-). Cells were incu-
bated in 1 ml of lysis buffer (20 mM Tris pH7.4, 2.5 mM
MgCl2, 200 mM NaCl, 0.05% NP40) for 10 min on ice,
and the cell lysates were cleared by centrifugation at
20000 ×g for 20 min at 4°C. Twenty μl of ProteinG cou-
pling beads (Dynal) bound with 5 μg of anti-human Ago2
antibody 4G8 (Wako) was added to cell lysate and mixed
by rotation for 2 hours at 4°C. The beads were then
washed three times with 1 ml lysis buffer, and bound
Ago2-RNA complex were eluted with 0.5% SDS solution.
Eluted complex was extracted with phenol/chloroform,
and the RNA was precipitated with ethanol.
Total RNA from cultured cells was extracted using ISO-
GEN (Nippon Gene). A small RNA fraction (< 200 nt) was
obtained using the mirVana™ miRNA Isolation Kit
(Ambion). Small RNA 20–24 nt long was purified from
the small RNA fraction by denatured 15% polyacrylamide
gel electrophoresis, treated with phenol/chloroform/iso-
amyl alcohol (25:24:1), and ethanol-precipitated.
Gel electrophoresis of immunoprecipitates
The immunoprecipitate from 5 × 106 cells was loaded
onto 10–20% SDS-polyacrylamide gel. After electro-
phoresis, the protein was stained with a Wako Silver stain-
ing kit (Wako). Western blot examination was performed
using anti-human Ago2 antibody 4G8.
The immunopurified RNA derived from 5 × 106 cells was
loaded onto 10% polyacrylamide TBE-Urea gel and run in
0.5 × TBE at 10 mA for 50 min. After electrophoresis, the
gel was silver stained with Clear stain Ag (Nippon Gene)
to check amounts of small RNA.
cDNA cloning of small RNA
The RNA was dephosphorylated with 1 unit of shrimp
alkaline phosphatase (USB) for 30 min at 37°C in 50 mM
Hepes (pH7.3), 5 mM MgCl2, and 10 mM KCl. Then a 5'
phosphate and 3' dideoxy modified 3' RNA adaptor (5'-
prArArGrArArGrCUrGrGrCrGUrCrArAUrGUddC-3') was
ligated with 10 units of ThermoPhage™ single-stranded
DNA ligase (PROKARIA) for 30 min at 60°C in 25 mM
Hepes (pH7.3), 2.5 mM MgCl2, 5 mM KCl, 0.05 mM ATP,
1 mM dithiothreitol (DTT), 25 ng/μl BSA. The reaction
liquid was treated with phenol/chloroform/isoamyl alco-
hol, and ethanol-precipitated. The 3' adaptor ligated RNA
and 2.5 μM of a first-strand primer (5'-GACATT-
GACGCCAGCTTCTT-3') with sequence complementary
to the ligated 3' RNA adaptor were mixed and the cDNA
was synthesized with 200 units of ReveScript IV reverse
transcriptase (Wako) for 30 min at 42°C in the manufac-
turer's 1 × reaction buffer (50 mM Tris-HCl, pH8.3, 75
mM KCl, 3 mM MgCl2, 5 mM DTT, 2 mM dNTPs with 20
units of Ribonuclease Inhibitor, Super (Wako)). The mix-
ture was incubated for 30 min at 65°C in 167 mM EDTA
and 53 mM NaOH to hydrolyze the RNA template. Then
the hydrolyzed reaction mixture was neutralized with 20
mM Tris-HCl, pH 7.5 and treated with phenol/chloro-
form/isoamyl alcohol, and ethanol-precipitated. The
remaining single-stranded cDNA was dephosphorylated
with shrimp alkaline phosphatase and ligated to the 5'
phosphated and 3' dideoxy modified 5' adaptor (5'-
pAAGGCTCAGTCTCGGGATAddC-3') with Ther-
moPhage™ single-stranded DNA ligase. The ligated cDNA
was amplified by 2-step PCR with 2.5 units of HotGold-
star™ DNA polymerase (Eurogentec) in the manufac-
turer's 1 × reaction buffer with 0.25 mM dNTPs, 5 μM of
5' PCR primer (5'-GTATCCCGAGACTGAGCC-3'), and 5
μM of 3' PCR primer (5'-GACATTGACGCCAGCTTC-3')
corresponding to 5' adaptor and 3' adaptor sequence,
respectively. The reaction was performed at 95°C for 10
min, 95°C for 20 sec, 56°C for 10 sec, and 72°C for 10
sec for 15 cycles, and 7(EtBr) staining. The purified PCRBMC Research Notes 2009, 2:169 http://www.biomedcentral.com/1756-0500/2/169
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product was amplified by a second PCR with the 2°C for
1 min. After the first 15 cycles, products were loaded on a
15% native polyacrylamide gel electrophoresis and 60–64
bp fragments were excised after ethidium bromide same
conditions as the first PCR, and the product was purified
by gel electrophoresis. The product was ligated to 20 ng of
pGEM T Easy Vector (Promega) with a DNA Ligation Kit
Mighty Mix (Takara Bio) and transfected into DH5α. Plas-
mid DNA was prepared with the QuickGene Plasmid Kit
S (FUJIFILM) and sequenced with the BigDye® Terminator
Cycle Sequencing Kit (Applied Biosystems). Each miRNA
was identified using the BLAST homology search program
http://blast.ddbj.nig.ac.jp/top-j.html.
cDNA cloning of anti-Ago2- immunoprecipitated mRNA
The first-strand cDNA was synthesized with 200 units of
ReveScript IV reverse transcriptase for 10 min at 42°C in
the manufacturer's buffer (50 mM Tris-HCl, pH8.3, 75
mM KCl, 3 mM MgCl2, 5 mM DTT, 2 mM dNTPs with 20
units of Ribonuclease Inhibitor, Super) using oligo-
dT(20) primer (5'-GACCATATGACGAGATCCGAGCT-
TCTTTTTTTTTTTTTTTTTTTT-3') with the sequence for
PCR amplification. Then the mixture was incubated for 30
min at 65°C in 167 mM EDTA and 53 mM NaOH to
hydrolyze RNA template. The hydrolyzed mixture was
neutralized with 20 mM Tris-HCl, pH 7.5 and purified
with the Invisorb® Spin PCRapid Kit (Invitek). Then the
second-strand cDNA was synthesized using 4 μM random
primers (5'-CATGGTATCGACGAGACTGAGGCTGNNNN
NNNNNB-3', N = A, C, G, T, B = C, G, T) containing the
sequence for subsequent PCR amplification with 2.5 units
of HotGoldstar™ DNA polymerase in the manufacturer's
reaction buffer with 0.2 mM dNTPs. The reaction was per-
formed at 95°C for 10 min, 30°C for 1 min, 40°C for 30
sec, 50°C for 30 sec, 60°C for 30 sec, 72°C for 2 min, and
95°C for 1 min, followed by chilling on ice for 1 min, and
cDNA was then purified with the Invisorb® Spin PCRapid
Kit. The double-stranded cDNA was amplified by PCR
with 2.5 units of HotGoldstar™ DNA polymerase in the
manufacturer's reaction buffer with 0.2 mM dNTPs and 4
μM each of the 5' PCR primer (5'-CATGGTATCGACGA-
GACTGAG-3') and 3' PCR primer (5'-GACCATATGACGA-
GATCCGAG-3'). The reaction was performed at 95°C for
10 min, 95°C for 20 sec, 60°C for 10 sec, and 72°C for 30
sec for 24 cycles, and 72°C for 2 min. The amplified cDNA
was purified with the Invisorb® Spin PCRapid Kit. The size
distribution of the cDNA was analyzed with the Bioana-
lyzer DNA 1000 Kit (Agilent Technologies). The residue of
purified PCR product was ligated to 20 ng of pGEM T Easy
Vector with DNA Ligation Kit Mighty Mix for 1 h at 16°C
to construct a cDNA library and transformed into DH5α.
Plasmid DNA was prepared with the QuickGene Plasmid
Kit S and sequenced with the BigDye® Terminator Cycle
Sequencing Kit. The identification of mRNA species corre-
sponding to each cDNA sequence was performed using
the BLAST homology search program. To detect micro-
RNA target sites in isolated mRNA, the microRNA target
prediction search program TargetScan 4.2 http://www.tar
getscan.org/index.html was used. In addition, mRNA
expression data for cells and tissues were searched using
the microarray database RefExA http://www.lsbm.org/.
Free Alu RNA or Alu RNA embedded mRNA was predicted
by a homology search against three types of human pri-
mary Alu transcript (GeneBank accession Nos. U67811,
U67812, and U67813) using GENETYX® (GENETYX) gene
analysis software, and molecules with greater than 60%
homology were classified as Alu RNA-related. 'Hit in
genome' demonstrates the sequences that were not cate-
gorized by BLAST search.
Quantitative-PCR
Reverse transcription of mRNA was performed using the
SuperScript VILO cDNA Synthesis Kit (Invitrogen) follow-
ing the manufacturer's instructions. Immunopurified
RNA (derived from all transfected cells) and 1 μg of total
RNA were used for reverse transcription. Quantitative-
PCR of mRNA was performed using gene specific primer
pairs and 2 × Power SYBR Master Mix (Applied Biosys-
tems) following the manufacturer's instructions. Quanti-
tative-PCR were performed on the ABI 7500 real-time PCR
system.
Results and Discussion
Isolation of endogenous Ago2 and miRNA complex
For the immunoprecipitation of Ago2 protein, we used an
anti-human Ago2 antibody 4G8, which has been
described for its immunoprecipitating activity and specif-
icity [13,22]. SDS-PAGE analysis of the immunoprecipi-
tates from human cell line extracts of HeLa, HepG2,
HEK293 and THP-1 but not of mouse cell line P388D1
yielded a clear Ago2 protein band of approximately 100
kDa. Also, PAGE analysis revealed a highly purified RNA
band of approximately 22 nucleotides long in the immu-
noprecipitates of all human cell lines tested (Additional
file 1). In addition, we also ascertained this procedure can
be applicable to the tissue extract. To profile the immu-
nopurified RNA, we performed a microarray analysis
using the μParaflo® microfluidics chip (LC Sciences) with
a complementary sequence of human 474 miRNAs on it
(miRBase release 9.0) and compared the profile with that
of total RNA. The miRNA profile of HeLa cell immunop-
urified RNA exhibited almost the same pattern with that
of total RNA (Additional file 2) suggesting that Ago2-
immunopurification could trap almost all expressed
miRNA species.BMC Research Notes 2009, 2:169 http://www.biomedcentral.com/1756-0500/2/169
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Construction of a simple and efficient method for cloning 
of miRNA
The cDNA of the isolated small RNA was synthesized by
improved adaptor ligation protocol see Methods section.
We utilized the unique features of ThermoPhage™ single-
stranded DNA ligase, which has ligase activities for both
single-stranded RNA and DNA and can be used at 60°C
[23]; this ligase was used for all of the adaptor ligation.
High temperature may be advantageous for the ligation of
nucleotides with tight tertiary structures. Using this
method, cDNA libraries for the Ago2-immunoprecipi-
tated RNA were produced, and the sequences of 96 clones
were analyzed. The contents of the clones are shown in
Figure 1A. Although significant amount of contamination
by junk cDNA fragments derived from adaptor or primer
sequences has been reported in other cloning methods
[24], no similar contamination was found in the library
made with our method. Moreover, marked reduction in
the number of rRNA and tRNA clones was observed, com-
pared to the other systems [24]. The profiles of cloned
miRNA are listed in Figure 1B. Though the number of
clones examined here may still be insufficient, these
results suggest the usefulness of our Ago2-immunoprecip-
itation/cloning system of Ago2-RISC-associated miRNAs.
Cloning of antibody-isolated mRNA
Since a significant amount of mRNA is known to be
immunoprecipitated with RISC-associated RNA, we
developed a cloning system for the trapped mRNA.
Because the mRNA content in the immunoprecipitates
from 107 cells was small and varied in size, we included a
PCR amplification step in the cloning of immunoprecipi-
tated mRNAs. To avoid PCR-derived bias due to the varia-
tion in the length of mRNA for cloning efficiency, we did
not aim to synthesize the full-length cDNA and used ran-
dom primers for the second-strand cDNA synthesis (Addi-
tional file 3). The human mRNA database is now almost
completed and the sequence information of 3' short
cDNA fragments is sufficient to identify each mRNA spe-
cies. Independence of the length and terminal cap struc-
ture of template RNA may be suitable for comprehensive
profiling of mRNAs. We tested the cloning efficiency of
three mRNA species with different lengths (albumin:
2122b, beta-actin: 1874b, GAPDH: 1380b). We mixed
them in equal amounts and confirmed nearly equal ratios
of cloning for these input mRNAs (15, 19, and 14 clones
from total 48 clones, respectively). With this protocol,
cDNA cloning of immunoprecipitated mRNA could be
achieved with relatively small amount of RNA prepared
from 1 × 107 cells.
A cDNA library for HeLa cell immunopurified mRNA was
constructed using this protocol. After the PCR amplifica-
tion step, quantity and molecular size of the synthesized
cDNAs were analyzed with the Bioanalyzer DNA 1000 Kit.
The size distribution of synthesized cDNAs is relatively
Categories of cDNA clones derived from immunoprecipitated small RNA of HeLa cells Figure 1
Categories of cDNA clones derived from immunoprecipitated small RNA of HeLa cells. A: Composition of small 
RNA cDNA clones. The composition of cDNA clones is shown in a circle graph. Almost all of the recovered cDNA was 
miRNA (94%), while the remainder was rRNA and tRNA clones (3% and 2%). 'Others' indicates the cDNA clones with hits in 
the genomic sequence. B: Contents of miRNA clones. Each miRNA clone was deduced by BLAST search. The y-axis indicates 
number of clones of each miRNA species.










OK4C
OK4C
OK4
OK4D
OK4
OK4
E
N
Q
P
G
U
PL51$
 
U51$
 
 
W51$ RWKHUV
 
A BBMC Research Notes 2009, 2:169 http://www.biomedcentral.com/1756-0500/2/169
Page 5 of 10
(page number not for citation purposes)
small with the size from 100 to 1,000 bp (Figure 2A).
cDNA synthesized from a control mouse IgG-immuno-
precipitated fraction exhibited no DNA bands indicating
that the cDNA could be synthesized specifically from anti-
Ago2 antibody-trapped mRNA.
We picked 91 clones and analyzed their sequences. The
profile of the cDNA clones deduced by BLAST search is
shown in Figure 2B, and all isolated mRNA clones are
listed in Additional file 4. Of the 91 clones, 79 clones
(86.8%) were identified as mRNA, and the average length
of inserted cDNA in the 91 clones was calculated to be
244.8 bp including a poly(A) tail of 31.5 bp. In the course
of this analysis, we noticed that the cloned cDNAs con-
tained a relatively high percentage of Alu-related
sequences. Of the mRNA clones, about 16.5% (13/79
clones) of clones harbored an Alu sequence in the 5'- or
3'-UTR sequences, whereas the percentage of Alu-contain-
ing mRNA in human mRNA species is reported to be
about 5% [25]. Alu elements can be transcribed in two dif-
ferent fashions, yielding 'free Alu RNAs', which are tran-
scribed from their own promoter, and 'embedded Alu
RNAs', which are transcribed as a part of coding RNAs
[26]. Based on the results from in silico analysis, it was
speculated that Alu RNAs embedded in 3'-UTRs are prob-
able miRNA targets [27]. Our findings may be the first to
show that mRNA with Alu sequences are concentrated in
RISC-associated mRNA, and suggest the regulation of
gene expression by miRNA through these sequences. A
substantial number of free Alu RNAs (4 clones) was also
found in the cDNA prepared from HeLa cell extract (Fig-
ure 2B). These free Alu RNA clones exhibited a high degree
of homology with each other, though none had the same
sequence (Additional file 5). In contrast, no cDNA clone
in the control IgG experiment has Alu sequence. In the
case of HepG2 cells (described in the later section), about
10% of total cDNA from Ago2-immunoprecipitated
mRNA were clones with the free Alu RNA sequence. These
data suggest the possible binding of free Alu RNAs to
some sort of miRNA.
Size distribution of synthesized cDNA and categories of cDNAs isolated from HeLa cells Figure 2
Size distribution of synthesized cDNA and categories of cDNAs isolated from HeLa cells. A: Size distribution pat-
tern of synthesized cDNA. The amount and size distribution of cDNA were determined with the Bioanalyzer DNA 1000 Kit. 
The red line indicates cDNA synthesized from anti-Ago2 immunoprecipitates, while the blue line indicates that from control 
mouse IgG. B: Composition of isolated cDNA clones. The sequences of 91 clones were examined by BLAST search and cate-
gorized as mRNA, Alu RNA embedded mRNA, free Alu RNA, or hits in the genome. The percentage recovery of each catego-
rized cDNA clone is shown. Alu RNA embedded mRNA (14.3%, not indicated in the figure) is included in the mRNA area 
(total 80%) and separated by a broken line.
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Changes in RISC-associated mRNA after miR-122 
introduction into HepG2 cells
We tested for our system whether the target mRNAs
against a desired miRNA can be screened or not using
miR-122 as a model system. The miR-122 is a hepato-spe-
cific miRNA, and its down-regulation is reported to be
correlated with tumorigenesis in the liver[28]. The human
hepatoma cell line HepG2 expresses little miR-122,
whereas normal liver cells express it abundantly. We intro-
duced miR-122 duplex or, as a control, firefly luciferase
siRNA (GL3) into HepG2 cells transiently and compared
the Ago2-associated mRNA profiles of these two types of
cells. After transfection of miR-122 duplex, cDNA cloning
of miRNA revealed that miR-122 comprised about 16% of
immunoprecipitated miRNA (Figure 3A). We did not
obtain any GL3 clones, but did obtain a clone of GL3 anti-
sense by GL3 transfection. GL3 was also expected to be
cloned like miR-122 so the reason for lack of clones is
unclear. After cDNA cloning of mRNA, we picked 289 and
269 clones from miR-122- and GL3-transfected cells
respectively, and all identified mRNA clones are listed in
Additional file 6.
(i) Changes in Alu RNA and mitochondrial mRNA in RISC
The compositions of cDNA isolated from Ago2-associated
miR-122- or GL3-transfected HepG2 cells are shown in
Figure 3B. Whereas the percentage of free Alu RNA
remained constant at about 10% of cDNA, that of Alu-
embedded mRNA decreased significantly after miR-122
transfection. These findings may have been obtained
because Alu-embedded mRNA does not have target
sequences against miR-122 [27]. From the miR-122-trans-
fected cells, substantial amounts of mitochondrial mRNA
were cDNA-cloned and almost all of which was COX3
(cytochrome c oxidase subunit 3) mRNA. However, since
mitochondrial mRNAs are retained inside of the mito-
chondria in cells, these findings must be artifactual. Since
COX3 mRNA has two miR-122 target sites, we speculate
Contents of miRNA and mRNA cDNA clones obtained from immunoprecipitates of miR-122- and GL3-transfected HepG2  cells Figure 3
Contents of miRNA and mRNA cDNA clones obtained from immunoprecipitates of miR-122- and GL3-trans-
fected HepG2 cells. A: Contents of miRNA clones. 89 clones were analyzed for the miR-122-transfectant and 84 for the 
GL3-transfectant. Red bars show recovered miRNA clones originating from transfected nucleotides (upper figure; miR-122-
transfected HepG2 cells, lower figure GL3-transfected HepG2 cells). B: Composition of RISC-associated polyA-containing 
RNA. The isolated cDNA clones were analyzed by BLAST search and classified into categories. The composition of each cate-
gorized RNA is shown (Upper figure: miR-122-transfected HepG2 cells, lower figure: GL3-transfected HepG2 cells). Alu RNA 
embedded mRNA is included in mRNA area. The percentages of Alu RNA embedded mRNA in the miR-122 and the GL3 
transfectants were 10% and 19%, respectively.
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that during cell lysis, abundant mitochondrial mRNA
leaks from the broken mitochondria and reacts with the
miR-122.
(ii) Possible approach to screening of miR-122 target mRNA
To search for miR-122 target sequences in mRNA, a
miRNA target prediction search program was applied to
all isolated clones. In Figure 4A, the cDNA clones contain-
ing miR-122 seed match sequences are listed. In the miR-
122-transfected HepG2 cells, of 220 mRNA clones, 15
clones had a miR-122 target site, 11 (10 types) of which
featured a high context score percentile (>50). In the case
of GL3 transfectants, 11 of 217 mRNA clones had a miR-
122 target site, 5 of which featured a high context score
percentile. As shown in Figure 4B, the clones with high
context score percentile for the miR-122 target site were
markedly enriched in RISC of miR-122-transfected
HepG2 cells.
We selected 17 mRNA clones with high context score per-
centile ( 40) from the miR-122- and GL3-transfectants,
and compared the mRNA content in the immunoprecipi-
tate with that in total RNA by real-time PCR. The differ-
ence in the RNA content of individual mRNA is shown in
Figure 5. Seven mRNA clones selected only from miR-122
transfectant (Figure 5A) were enriched in RISC of the miR-
122-transfectants. And since total RNA amounts of four of
these clones, ALDOA (aldolase A, fructose-bisphosphate),
PIGS (phosphatidylinositol glycan anchor biosynthesis,
class S), SLC1A5 (solute carrier family 1 (neutral amino
Selection of target mRNA candidate for miR-122 Figure 4
Selection of target mRNA candidate for miR-122. A: List of cDNA clones with miR-122 seed match sequence in 3'UTR. 
All isolated clones were searched for the miR-122 target site by the miRNA target prediction program TargetScan 4.2, and the 
clones exhibiting context score percentiles (csp) are listed in the box. The left box shows the clones isolated from the miR-
122-transfectant, and the right box shows those isolated from the GL3-transfectant. B: Enrichment of recovered cDNA clone 
containing miR-122 target site with high csp after miR-122 transfection. The numbers of cDNA clones with csp values for the 
miR-122 target site categorized as low (1–49), intermediate (50–79), and high (80–100) are shown separately. The blue bar 
shows the number of clones recovered from the miR-122 transfectant, while the purple bar shows those recovered from the 
GL3 transfectant.
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acid transporter), member 5) and SLC7A5 (solute carrier
family 7 (cationic amino acid transporter y+system),
member 5) were decreased in the miR-122 transfectants,
these mRNAs are thought to be candidates of miR-122 tar-
get. These 4 clones is likely to be down-regulated through
interaction with miR-122. In fact, in the RefExA microar-
ray database, these 4 mRNAs are expressed at higher levels
in HepG2 cells where less miR-122 is expressed than in
normal liver with abundant miR-122. With the exception
of ALDOA, these mRNAs have not yet been reported as
miR-122 targets. To address this issue, other experiments
such as translation repression assays may be necessary.
Among these candidates, SLC1A5 and SLC7A5 belong to
the amino acid transporters and expressions of these
transporters are thought to be necessary for the growth of
human liver cancer cells [29], and over-expression of
SLC1A5 and SLC7A5 in liver cancer cells may correlate
with a low miR-122 level.
Eventhough the number of clones we examined was very
limited and comprised only a portion of libraries we
obtained, several miR-122 target candidates could be
picked up. We believe that these results show the potential
of our protocol for isolating the miRNA targets.
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Additional material
Additional file 1
Anti-human Ago2 monoclonal antibody (4G8) specifically immuno-
precipitates human Ago2 and associated small RNA. A: SDS-PAGE 
pattern of immunoprecipitates. Lysates of human cell lines (HeLa, 
HepG2, HEK293, and THP-1) and a mouse cell line (P388D1) were 
immunoprecipitated with anti-hAgo2 (4G8). Proteins were analyzed by 
SDS-PAGE and subjected to silver staining or western blotting with anti-
hAgo2 (4G8). Half of the immunoprecipitated protein prepared from 1 × 
107 cells was loaded onto an SDS-polyacrylamide gel. IgG h.c. and l.c. 
indicate heavy chain and light chain of the antibody molecule, respec-
tively. B: Recovery of small RNA from immunoprecipitates. Immunopre-
cipitated small RNAs were analyzed by Urea-PAGE and silver stained. 
The RNA fraction prepared from half of the immunoprecipitate from 1 × 
107 cells was loaded onto Urea-polyacrylamide gel.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-2-169-S1.ppt]
Changes in mRNA level in total and Ago2-associated RNA after miR-122 transfection Figure 5
Changes in mRNA level in total and Ago2-associated RNA after miR-122 transfection. Seventeen clones with high 
score percentile for the miR-122 target site (> = 40) were picked, and the mRNA levels in total and immunoprecipitated RNA 
were quantified by RT-PCR. In the figure, the ratios of the amount of mRNA in the miR-122-transfected cells to that in the 
GL3-transfected cells are shown. Blue bars indicate the ratio for Ago2-associated RNA, while purple bars show that for total 
RNA. The left panel shows the clones picked from the miR-122-transfected cells, and the right panel shows the clones picked 
from the GL3-transfected cells (See Figure 6A). The clones are aligned in order of height of context score percentile from the 
left, with the ratio for GAPDH inserted as a standard.
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